Health Care & Life Sciences » Pharmaceuticals | Hindustan Bio Sciences Ltd.

Hindustan Bio Sciences Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
22,537.70
7,498.10
12,600.80
10,125.00
10,311.00
35,634
Cost of Goods Sold (COGS) incl. D&A
23,788.90
17,440.80
11,468.90
10,056.80
7,975.00
31,216
Gross Income
1,251.20
9,942.70
1,131.90
68.20
2,336.00
4,418
SG&A Expense
7,720.50
3,973.80
2,471.60
4,831.30
25,932.00
3,197
EBIT
8,971.70
14,031.50
1,339.70
4,763.00
23,596.00
1,221
Unusual Expense
-
-
19,229.50
-
-
-
Non Operating Income/Expense
674.90
136.30
-
-
922.00
6
Interest Expense
277.50
312.80
260.00
110.40
38.00
104
Pretax Income
9,924.10
14,480.60
20,829.10
4,873.50
22,712.00
1,123
Income Tax
1.80
71.80
48.70
41.80
40.00
23
Consolidated Net Income
9,922.30
14,552.40
20,877.80
4,915.20
22,752.00
1,100
Net Income
9,922.30
14,552.40
20,877.80
4,915.20
22,752.00
1,100
Net Income After Extraordinaries
9,922.30
14,552.40
20,877.80
4,915.20
22,752.00
1,100
Net Income Available to Common
9,922.30
14,552.40
20,877.80
4,915.20
22,752.00
1,100
EPS (Basic)
0.97
1.42
2.04
0.48
2.22
0.11
Basic Shares Outstanding
10,250.80
10,250.80
10,250.80
10,250.80
-
-
EPS (Diluted)
0.97
1.42
2.04
0.48
-
-
Diluted Shares Outstanding
10,250.80
10,250.80
10,250.80
10,250.80
-
-
EBITDA
6,803.00
12,186.10
1,229.50
4,657.30
23,500.00
1,328
Other Operating Expense
-
115.00
-
-
-
-

About Hindustan Bio Sciences

View Profile
Address
H. No. 8-2-269/S, Road No. 2
Hyderabad TS 500034
India
Employees -
Website http://www.hindustanbiosciences.in
Updated 07/08/2019
Hindustan Bio Sciences Ltd. provides various services in the pharmaceutical and biotechnology sectors. Its product portfolio includes liquid injectables, liquid and dry syrups, eye, ear and nasal drops, pre-filled syringes and non sterile and sterile ointments, tablets and capsules. Its products include erythropoietin, APIs, drug intermediates and specialty fine chemicals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.